| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 7151 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 5715 | 2012 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The Lancet 388 (10053), 1659-1724, 2016 | 2550 | 2016 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … II Abubakar, T Tillmann, A Banerjee Lancet 385 (9963), 117-171, 2015 | 2353 | 2015 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The Lancet 386 (9995), 743-800, 2015 | 2042 | 2015 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The Lancet 388 (10053), 1545-1602, 2016 | 1255 | 2016 |
| Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 NJ Kassebaum, A Bertozzi-Villa, MS Coggeshall, KA Shackelford, ... The Lancet 384 (9947), 980-1004, 2014 | 1127 | 2014 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet, 2015 | 1013 | 2015 |
| Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 CJL Murray, KF Ortblad, C Guinovart, SS Lim, TM Wolock, DA Roberts, ... The Lancet 384 (9947), 1005-1070, 2014 | 860 | 2014 |
| Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... The Lancet Global Health 5 (9), e888-e897, 2017 | 499 | 2017 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the … NJ Kassebaum, M Arora, RM Barber, ZA Bhutta, J Brown, A Carter, ... The Lancet 388 (10053), 1603-1658, 2016 | 398 | 2016 |
| A corneal flap technique for laser in situ keratomileusis: human studies IG Pallikaris, ME Papatzanaki, DS Siganos, MK Tsilimbaris Archives of ophthalmology 109 (12), 1699-1702, 1991 | 396 | 1991 |
| Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... The Lancet Global Health 5 (12), e1221-e1234, 2017 | 340 | 2017 |
| Ocular rigidity in living human eyes IG Pallikaris, GD Kymionis, HS Ginis, GA Kounis, MK Tsilimbaris Investigative ophthalmology & visual science 46 (2), 409-414, 2005 | 288 | 2005 |
| Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010 RRA Bourne, JB Jonas, SR Flaxman, J Keeffe, J Leasher, K Naidoo, ... British Journal of Ophthalmology 98 (5), 629-638, 2014 | 254 | 2014 |
| Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update VR Participants Retina 25 (2), 119-134, 2005 | 174 | 2005 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 150 | 2018 |
| Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey D Husain, I Kim, D Gauthier, AM Lane, MK Tsilimbaris, E Ezra, ... Archives of Ophthalmology 123 (4), 509-516, 2005 | 107 | 2005 |
| Prevalence and causes of vision loss in sub-Saharan Africa: 1990–2010 K Naidoo, S Gichuhi, MG Basáñez, SR Flaxman, JB Jonas, J Keeffe, ... British Journal of Ophthalmology 98 (5), 612-618, 2014 | 78 | 2014 |
| Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure AI Dastiridou, HS Ginis, D De Brouwere, MK Tsilimbaris, IG Pallikaris Investigative ophthalmology & visual science 50 (12), 5718-5722, 2009 | 76 | 2009 |
Ioannis G. PallikarisUniversity of Crete Medical SchoolVerified email at med.uoc.gr
